DK1512004T3 - Fremgangsmåde til kortlægning og eliminering af T-celleepitoper - Google Patents

Fremgangsmåde til kortlægning og eliminering af T-celleepitoper

Info

Publication number
DK1512004T3
DK1512004T3 DK03740219T DK03740219T DK1512004T3 DK 1512004 T3 DK1512004 T3 DK 1512004T3 DK 03740219 T DK03740219 T DK 03740219T DK 03740219 T DK03740219 T DK 03740219T DK 1512004 T3 DK1512004 T3 DK 1512004T3
Authority
DK
Denmark
Prior art keywords
epitopes
identification
mapping
eliminating
cell epitopes
Prior art date
Application number
DK03740219T
Other languages
Danish (da)
English (en)
Inventor
Matthew Baker
Francis J Carr
Graham Carter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29724386&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1512004(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK1512004T3 publication Critical patent/DK1512004T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
DK03740219T 2002-06-11 2003-06-11 Fremgangsmåde til kortlægning og eliminering af T-celleepitoper DK1512004T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02012919 2002-06-11

Publications (1)

Publication Number Publication Date
DK1512004T3 true DK1512004T3 (da) 2006-06-06

Family

ID=29724386

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03740219T DK1512004T3 (da) 2002-06-11 2003-06-11 Fremgangsmåde til kortlægning og eliminering af T-celleepitoper

Country Status (16)

Country Link
EP (1) EP1512004B1 (ja)
JP (1) JP2005529170A (ja)
CN (1) CN100401064C (ja)
AT (1) ATE320603T1 (ja)
AU (1) AU2003273679A1 (ja)
BR (1) BR0311720A (ja)
CA (1) CA2489180A1 (ja)
DE (1) DE60304040T2 (ja)
DK (1) DK1512004T3 (ja)
ES (1) ES2257680T3 (ja)
MX (1) MXPA04012209A (ja)
PL (1) PL371675A1 (ja)
PT (1) PT1512004E (ja)
RU (1) RU2334235C2 (ja)
WO (1) WO2003104803A2 (ja)
ZA (1) ZA200500214B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05008704A (es) * 2003-02-18 2005-10-05 Merck Patent Gmbh Proteinas de fusion de muteinas de interferon alfa con propiedades mejoradas.
NZ550339A (en) 2004-03-19 2009-11-27 Merck Patent Gmbh Modified bouganin proteins, cytotoxins and methods and uses thereof
FR2940451B1 (fr) 2008-12-18 2014-09-12 Proteus Procede d'evaluation de l'immunogenicite des proteines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001349A (en) * 1995-02-22 1999-12-14 Therion Biologics Corporation Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
US5945401A (en) * 1995-06-23 1999-08-31 Conlon; Paul J. Peptide analogues of the 65KD isoform of human glutamic acid decarboxylase and uses thereof
US6165460A (en) * 1995-07-10 2000-12-26 Therion Biologics Corporation Generation of immune responses to prostate-specific antigen (PSA)
US6737406B1 (en) * 1996-03-21 2004-05-18 Circassia, Ltd. Cryptic peptides and method for their identification
US5750356A (en) * 1996-05-31 1998-05-12 Anergen, Inc. Method for monitoring T cell reactivity
ES2258817T3 (es) * 1997-05-21 2006-09-01 Biovation Limited Metodo para la produccion de proteinas no inmunogenas.
EP1051432B1 (en) * 1998-12-08 2007-01-24 Biovation Limited Method for reducing immunogenicity of proteins
DE60144399D1 (de) * 2000-10-02 2011-05-19 Danisco Us Inc Methode zur bestimmung der immunogenität von proteinen, die eine veränderte immunantwort hervorrufen

Also Published As

Publication number Publication date
EP1512004B1 (en) 2006-03-15
CN1659437A (zh) 2005-08-24
DE60304040D1 (de) 2006-05-11
PT1512004E (pt) 2006-08-31
RU2334235C2 (ru) 2008-09-20
AU2003273679A1 (en) 2003-12-22
ES2257680T3 (es) 2006-08-01
MXPA04012209A (es) 2005-02-25
ATE320603T1 (de) 2006-04-15
CN100401064C (zh) 2008-07-09
JP2005529170A (ja) 2005-09-29
DE60304040T2 (de) 2006-09-28
ZA200500214B (en) 2006-02-22
RU2005100758A (ru) 2006-01-20
PL371675A1 (en) 2005-06-27
BR0311720A (pt) 2005-03-01
EP1512004A2 (en) 2005-03-09
WO2003104803A3 (en) 2004-04-15
WO2003104803A2 (en) 2003-12-18
CA2489180A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
DK1553975T3 (da) Optimerede Fc-varianter og fremgangsmåder til generering heraf.
HK1074670A1 (en) Sets of digital antibodies directed against short epitopes, and methods using same
DK1259547T3 (da) Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf
DK1532261T3 (da) Fremgangsmåder og DNA-konstrukter til produktion af polypeptider med højt udbytte
DK1699822T3 (da) IL-7-fusionsproteiner med antistofdele, fremstilling deraf og anvendelse deraf
ECSP067073A (es) Anticuerpos anti-il-13 y complejos
NO20014584D0 (no) Proteinisolering og -analyse
AU2003224674A8 (en) Compounds and methods for analyzing the proteome
DK1697523T3 (da) Ekspressionsvektor til antibiotikafri ekspression
BRPI0513135A (pt) bibliotecas de polinucleotìdeos, método de produção das mesmas, método de identificação de um polinucleotìdeo, região de ligação, meio adequado para uso em um, dispositivo eletrÈnico e dispositivo
DK1572087T3 (da) Antistoffer med cancerantigen TMEFF2 og anvendelser deraf
WO2003068941A3 (en) Modulation of immune response by non-peptide binding stress response polypeptides
BRPI0512798A (pt) molécula de ácido nucleico recombinante, célula, método para produzir uma proteìna de interesse, uso de uma seqüência de ácido nucleico tendo atividade anti-repressora, métodos para gerar uma célula hospedeira expressando dois polipeptìdios de interesse, e para expressar dois polipeptìdios de interesse
ZA200500214B (en) Method for mapping and eliminating T-cell epitopes.
DK0840620T3 (da) IL-8-antagonister til behandling af astma
DE60025704D1 (de) Das goodpasture-antigen bindende protein
DK1506235T3 (da) Fremgangsmåde til produktion af monoklonale antistoffer
DK1141026T3 (da) Sammensætninger og fremgangsmåder til frembringelse af monoklonale antistoffer repræsentative for en specifik celletype
MY144766A (en) Plant virus coat fusion proteins with gdf8 epitopes and vaccines thereof
WO2004003221A3 (en) Methods for peptide-protein binding prediction
DK1386160T3 (da) Fremgangsmåde til påvisning af blodcelle-antigener og antistoffer rettet mod disse
NO20080409L (no) Fremgangsmater og preparater til malsoking av IFNAR2
DK2275556T3 (da) Hurtig fremgangsmåde til screening af translationsfusionspartnere til fremstilling af rekombinante proteiner og translationsfusionpartnere screenet derfra
DK1208213T3 (da) Fremgangsmåde til fremstilling af proteiner i værtsceller under anvendelse af chaperoniner
NO20006112D0 (no) BASB027-proteiner og gener fra Moraxella Catarrhalis, antigener, antistoffer, og anvendelser